Rejection, Transplant Completed Phase 1 Trials for Sirolimus (DB00877)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01236378Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant RecipientsTreatment